Image3_Safety confirmation of induced pluripotent stem cell-derived cardiomyocyte patch transplantation for ischemic cardiomyopathy: first three case reports.jpeg

Image3_Safety confirmation of induced pluripotent stem cell-derived cardiomyocyte patch transplantation for ischemic cardiomyopathy: first three case reports.jpeg

Introduction<p>With the expected increase in patients with heart failure and ischemic 15 cardiomyopathy, the development of myocardial regenerative medicine using cell transplantation as a novel treatment method is progressing. This first-in-human clinical trial aimed to confirm the safety of...

Full description

Saved in:
Bibliographic Details
Main Author: Takuji Kawamura (651807) (author)
Other Authors: Yoshito Ito (1977811) (author), Emiko Ito (651810) (author), Maki Takeda (13252164) (author), Tsubasa Mikami (14501384) (author), Takura Taguchi (16988997) (author), Noriko Mochizuki-Oda (13252167) (author), Masao Sasai (1946722) (author), Tomomi Shimamoto (13252170) (author), Yukako Nitta (13252173) (author), Daisuke Yoshioka (2037379) (author), Masashi Kawamura (14501378) (author), Ai Kawamura (651809) (author), Yusuke Misumi (14501381) (author), Yasushi Sakata (435265) (author), Yoshiki Sawa (219191) (author), Shigeru Miyagawa (310845) (author)
Published: 2023
Subjects:
Cardiology
Cardiology (incl. Cardiovascular Diseases)
Cardiorespiratory Medicine and Haematology not elsewhere classified
cardiomyocyte patch transplantation
iPS cells
myocardial regenerative medicine
heart failure
immune response
HLA antibodies
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items